You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ATG

Showing 26 - 50 of 702
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

Diabetes, Type 1 Trial in Worldwide (Anti-Human Thymocyte Immunoglobulin, Rabbit)

Recruiting
  • Diabetes Mellitus, Type 1
  • Anti-Human Thymocyte Immunoglobulin, Rabbit
  • Graz, Austria
  • +14 more
Feb 23, 2022

Bacterial Vaginosis, Vaginal Disease, Bacterial Infections Trial in Randwick (Experimental: Low dose LABTHERA-001 capsule,

Recruiting
  • Bacterial Vaginosis
  • +4 more
  • Experimental: Low dose LABTHERA-001 capsule
  • +5 more
  • Randwick, New South Wales, Australia
    Scientia Clinical Research
Jan 30, 2023

Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation
  • Severe Combined Immune Deficiency (SCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022

Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

Recruiting
  • Aplastic Anemia
  • +2 more
  • Beijing, China
    Peking union medical college hospital
Aug 20, 2023

1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer Trial in Chongqing (ATG-008,

Not yet recruiting
  • 1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer
  • Chongqing, Chongqing, China
    Chongqing Cancer Hospital
Aug 4, 2021

Relapse/Refractory Multiple Myeloma Trial in China (ATG-010)

Completed
  • Relapse/Refractory Multiple Myeloma
  • Beijing, Beijing, China
  • +16 more
Jul 27, 2022

Diabetes, Type 1 Trial in Milan (Human pancreatic islet, ATG, Pegylated G-CSF)

Active, not recruiting
  • Diabetes Mellitus, Type 1
  • Human pancreatic islet
  • +3 more
  • Milan, Italy
    IRCCS San Raffaele Scientific Institute
Dec 1, 2022

Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

Recruiting
  • Hematologic Malignancy
  • Myeloid Malignancy
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Nov 7, 2022

Diabetes, Type 1, Hypoglycemia, Autoimmune Diseases Trial in Miami (Anti-Thymocyte Globulin (ATG), Interleukin 2, Exenatide)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +3 more
  • Anti-Thymocyte Globulin (ATG)
  • +7 more
  • Miami, Florida
    Diabetes Research Institute, University of Miami Miller School o
Feb 23, 2022

Graft-versus-host-disease, Relapse Trial in Calgary (Treatment Arm - high dose ATG, Control Arm - standard of care)

Recruiting
  • Graft-versus-host-disease
  • Relapse
  • Treatment Arm - high dose ATG
  • Control Arm - standard of care
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Oct 14, 2022

CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)

Not yet recruiting
  • Central Nervous System Lymphoma
  • Hefei, Anhui, China
  • +4 more
Jan 26, 2023

Aplastic Anemia Trial in Tianjin (Avatrombopag 20 MG Oral Tablet)

Recruiting
  • Aplastic Anemia
  • Avatrombopag 20 MG Oral Tablet
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Oct 4, 2022

Severe Aplastic Anemia Trial in Boston, Salt Lake City (drug, procedure, radiation)

Recruiting
  • Severe Aplastic Anemia
  • Boston, Massachusetts
  • +1 more
Jan 13, 2023

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)

Recruiting
  • Acute Leukemia
  • mitoxantrone liposome
  • ATG
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Feb 13, 2023

DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)

Recruiting
  • DLBCL Germinal Center B-Cell Type
  • Guangzhou, Guangdong, China
  • +5 more
Aug 16, 2022

Renal Transplantation Trial (TCD601, belatacept, ATG)

Not yet recruiting
  • Renal Transplantation
  • TCD601
  • +5 more
  • (no location specified)
Dec 20, 2022

Severe Aplastic Anemia Trial run by the NHLBI (ATG+Rapamune+cyclosporine, ATG+cyclosporine)

Completed
  • Severe Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2021

Lymphocyte Count, ATG Dose and Incidence and Severity of GVHD in

Completed
  • Hematopoietic Stem Cell Transplantation
  • Lower lymphocyte/ATG ratio
  • Higher lymphocyte/ATG ratio
  • Trieste, Italy
    Institute for Maternal and Child Health - IRCCS "Burlo Garofolo"
Apr 28, 2021

Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease Trial in Australia, Canada (Cyclophosphamide, Anti-Thymocyte

Recruiting
  • Acute Leukemia
  • +2 more
  • Darlinghurst, New South Wales, Australia
  • +8 more
Aug 30, 2021

GVHD, Acute Trial in Shanghai (PT-CY-FK +/-ATG)

Completed
  • GVHD, Acute
  • PT-CY-FK +/-ATG
  • Shanghai, Shanghai, China
    Rui Jin Hospital
May 19, 2021

Anemia, Aplastic, Anemia, Hypoplastic Trial run by the NHLBI (h-ATG (ATGAM ), Cyclosporine (Gengraf ))

Completed
Has Results
  • Anemia, Aplastic
  • Anemia, Hypoplastic
  • h-ATG (ATGAM )
  • Cyclosporine (Gengraf )
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 1, 2021

Advanced Solid Tumor Trial in Chongqing, Chengdu (ATG-008, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • Chongqing, Chongqing, China
  • +1 more
May 13, 2021